Trends and Complications after the LACC Trial with Gabriella Schivardi

IJGC Podcast

Conteúdo fornecido por BMJ Group. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por BMJ Group ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.

3M ago 25:38

MP3•Home de episódios

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Gabriella Schivardi to discuss trends and complications after the LACC Trial. Dr. Schivardi is a first year ESGO fellow at the European Institute of Oncology in Milan and a research collaborator at the Gynecologic Oncology Department at Mayo Clinic, Rochester, United States. In addition, she is a former fellow for the IJGC.

Highlights:

The study observed a significant decrease in the use of the minimally invasive approach after the publication of the LACC trial.
Within our population the 30-day major complication, minor complication, and unplanned hospital readmission rates remained stable between the pre- and post-LACC periods.
The study observed an increased rate accross the publication of the LACC trial limited to the intra and post-operative transfusion rate.
The lack of a rise in 30-day complication rates after the LACC trial publication supports the use of laparotomy as the standard of care.

356 episódios

#Medicine #BMJ Group #Fitness #Pedro Ramirez